Leerink Partners Maintains Market Perform on Amgen, Raises Price Target to $464

Benzinga · 1d ago
Leerink Partners analyst David Risinger maintains Amgen (NASDAQ:AMGN) with a Market Perform and raises the price target from $395 to $464.